Just when the U.S. thought it might be running out of vaccine intenders, the FDA officially approved Pfizer’s COVID-19 vaccine. The agency’s approval, along with the steady percentage of Americans who report severe concern about the Delta variant, has created a shift in perspective about getting inoculated.
This week, Americans say they are somewhat less concerned about being in public spaces than they were last week, although, the number of people who say they are “very concerned” about the Delta variant remains elevated.
Twenty-two percent of people who have yet to be vaccinated against COVID-19 indicate there is some level of likelihood that they will opt for inoculation.
Survey respondents under 35 have historically been the least concerned about being in public and also the least likely to receive the vaccine. However, in the last week, this age group has made significant gains in vaccine intent as a result of the FDA sanctioning the Pfizer vaccine.
Overall comfort levels for doing most day-to-day activities have also increased in time with the FDA’s announcement. Economic sentiment is also improving, particularly around making major purchases and buying a home.
Want to stay up to date with CivicScience’s weekly COVID-19 Impact Report and how the Delta variant is impacting consumer behavior? Sign up to receive the latest insights and up-to-the-minute data here.
